Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01606501
Other study ID # W81XWH-09-2-0108-OUT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2012
Est. completion date September 20, 2019

Study information

Verified date March 2021
Source Major Extremity Trauma Research Consortium
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary aim this prospective longitudinal observational outcomes study is to compare 18 month functional outcomes and health related quality of life (HRQoL) of patients undergoing salvage versus amputation following severe distal tibia, ankle and/or foot fractures with major soft tissue, bone and/or ankle articular surface loss. Functional outcomes and HRQoL will be measured using well established self reported measures, including the Veterans Rand Health Survey (VR-12) and the Short Musculoskeletal Functional Assessment (SMFA). Hypothesis 1: As a group, salvage patients with severe distal tibia, ankle and/or foot injuries with major soft tissue, bone and/or ankle articular surface loss will have similar functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury). Hypothesis 2: The subgroup of salvage patients who have either (1) a soft tissue injury that requires tissue transfer; (2) articular damage requiring arthrodesis of the ankle joint; or (3) bone loss at the distal tibia or ankle will have better functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury).


Recruitment information / eligibility

Status Completed
Enrollment 664
Est. completion date September 20, 2019
Est. primary completion date September 20, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. Patients with an injury that meets at least one of the following: 1. Gustilo type III pilon fractures consistent with one of the following OTA codes: 43B1.3, 43B2-B3, 43C, 44B, 44C 2. Gustilo type III B or C ankle fractures 3. Gustilo type III mid and/or hind foot fractures consistent with one of the following OTA codes: 81B2-B3, 82B and 82C 4. Open foot crush or blast injuries from high energy mechanism involving the mid and /or hind foot with significant soft tissues damage 5. Other severe foot injury (including closed foot crush or blast injuries) 2. Ages 18-60 inclusive. 3. Admitted to the hospital prior to definitive wound closure. Inclusion notes: 1. Patients may have other injuries except as noted below under exclusion criteria. 2. Foot crush and blast injuries are eligible if they are considered to be at significant risk for impaired outcome with moderate to severe disability and typically include one of the following associated injuries: 1. ankle dislocation (80A) 2. subtalar dislocation (80B) 3. extruded talus 4. chopart dislocation (80C) 5. multiple midfoot dislocations (80C) 6. three or greater proximal metatarsal fractures 7. heel pad/plantar degloving 8. extensive muscle necrosis in an open injury from crush, ischemia and/or foot compartment syndrome 3. These injuries may include "toe-pan" injuries from motor vehicle accidents and crush-like injuries from motorcycle accidents, and traumatic amputations. Exclusion Criteria: 1. Patient has a Glasgow Coma Scale motor score of 0-4 or a Glasgow Coma Scale motor score of 5 with a significant traumatic brain injury (defined as an AIS code of 5 or 6) at time of consent 2. Patient has third degree burns on >10% total surface area affecting the study limb 3. Patient has a previous leg or foot amputation of either limb 4. Patient is non-ambulatory due to an associated complete spinal cord injury 5. Patient non-ambulatory pre-injury 6. Patient speaks neither English nor Spanish 7. Patient likely to have severe problems with maintaining follow- up due to at least one of the following: 1. Patient has been diagnosed with a severe psychiatric condition 2. Patient is intellectually challenged without adequate family support 3. Patient lives outside the hospital's catchment area 4. Follow-up is planned at another medical center 5. Patients who are prisoners or homeless

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Maryland Medical Center Baltimore Maryland
United States University of Alabama at Birmingham Birmingham Alabama
United States Carolinas Medical Center Charlotte North Carolina
United States University of Virginia Charlottesville Virginia
United States MetroHealth Cleveland Ohio
United States Denver Health and Hospital Authority Denver Colorado
United States Duke University Medical Center Durham North Carolina
United States Orthopaedic Associates of Michigan Grand Rapids Michigan
United States Penn State Hershey Medical Center Hershey Pennsylvania
United States University of Texas Health Science Center at Houston Houston Texas
United States Eskenazi Health Indianapolis Indiana
United States OrthoIndy Methodist Hospital Indianapolis Indiana
United States St. Vincent Indianapolis Hospital Indianapolis Indiana
United States University of Iowa Medical Center Iowa City Iowa
United States University of Mississippi Medical Center Jackson Mississippi
United States Jamaica Hospital Medical Center Jamaica New York
United States University of Miami Ryder Trauma Center Miami Florida
United States Hennepin County Medical Center Minneapolis Minnesota
United States Vanderbilt Medical Center Nashville Tennessee
United States Oklahoma University Medical Center Oklahoma City Oklahoma
United States Orlando Regional Medical Center Orlando Florida
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania
United States Rhode Island/ Brown University Providence Rhode Island
United States Barnes Jewish Hospital Saint Louis Missouri
United States St. Louis University Medical Center Saint Louis Missouri
United States San Antonio Military Medical Center San Antonio Texas
United States Navy Medical Center San Diego San Diego California
United States University of California San Francisco Medical Center San Francisco California
United States University of Washington/Harborview Medical Center Seattle Washington
United States Florida Orthopaedic Institute, St. Joseph's Hospital Tampa Florida
United States Florida Orthopaedic Institute, Tampa General Hospital Tampa Florida
United States Walter Reed National Military Medical Center Washington District of Columbia
United States Wake Forest Baptist Medical Center Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Major Extremity Trauma Research Consortium

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient reported function and health related quality of life Functional Outcomes and health related quality of life will be measured using well established self reported measures, including the Veterans RAND Health Survey (VR-12) and the Short Musculoskeletal Functional Assessment (SMFA). 18 months
Secondary Physical impairment Physical impairment will be determined using objective performance measures of agility (4 step square test and Illinois Agility Test), strength and power (sit-to-stand test and timed stair climb), speed (self-selected walking speed and 40 yard shuttle run), postural stability (single leg stance) and overall activity will be measured using the step watch activity monitor. 18 months
Secondary Levels of participation Levels of participation will be measured using self reported measures of return to usual major activity (work, active duty, school, home management) and the Paffenbarger Activity Scale (PPAQ) that measures participation in light, moderate and vigorous recreational or sports activities. 18 months